Artificial Intelligence | News | Insights | AiThority
[bsfp-cryptocurrency style=”widget-18″ align=”marquee” columns=”6″ coins=”selected” coins-count=”6″ coins-selected=”BTC,ETH,XRP,LTC,EOS,ADA,XLM,NEO,LTC,EOS,XEM,DASH,USDT,BNB,QTUM,XVG,ONT,ZEC,STEEM” currency=”USD” title=”Cryptocurrency Widget” show_title=”0″ icon=”” scheme=”light” bs-show-desktop=”1″ bs-show-tablet=”1″ bs-show-phone=”1″ custom-css-class=”” custom-id=”” css=”.vc_custom_1523079266073{margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”]

Prognos Health and Mirador Analytics Form Strategic Partnership to Streamline Expert Determination for Patient-Level Data

Prognos Health, a leading healthcare analytics platform company, and Mirador Analytics, the leading HIPAA expert determination provider, announced a strategic partnership to provide Prognos clients with a more streamlined end-to-end HIPAA certification process that reduces risk.

Recommended AI News: EDJX To Present Breakthrough IoT and Edge Computing Partnership Use Cases at IoT Evolution Expo

“At Prognos, we are committed to maintaining the highest level of privacy and security for our data and our technology. This partnership with Mirador is an extension of that promise,” said Jason Bhan, MD, co-founder and chief medical officer, Prognos Health. “By working with Mirador to integrate their leading expert determination services and support into our prognosFACTOR platform, our clients can be assured that our analytics or data purchase options on our marketplace are fully de-identified and compliant with HIPAA privacy regulations.”

Related Posts
1 of 33,923

By partnering with Mirador Analytics, Prognos is able to utilize a suite of programmatic tests to assess the risk of re-identification in healthcare datasets, tools to determine dataset compliance, and have access to an automated approach to removing elements that present any potential risk for re-identification.

Recommended AI News: Xybion Adds Over $6.5 Million of Total Contracted Revenue from Seven New Pristima XD Deals

“At Mirador, we understand that organizations need more agile access and greater value from healthcare data and so we help them to innovate and improve care quality without compromising compliance and patient confidentiality. We’re excited to partner with Prognos because they have something unique – the ability to link lab test result data with other, more traditional and emerging datasets at scale,” shared Jamie Blackport, founder and chief executive officer, Mirador Analytics. “We look forward to expanding our partnership to accelerate our expert-led risk monitoring automation processes within the Prognos environment.”

To continue improving scalability, Prognos Health and Mirador Analytics seek to further develop the partnership in the future to provide an even faster, more automated process using a SaaS model embedded within Prognos Health’s prognosFACTOR platform.

Recommended AI News: ServicePower Expands Partnership Program

Comments are closed.